Ablative fractional laser treatment reduces hedgehog pathway gene expression in murine basal cell carcinomas
Lasers in Medical Science · 2024
DOI: 10.1007/s10103-024-03997-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lasers in Medical Science, 2024. Verfasst von Kristian Kåber Pedersen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Copenhagen University Hospital Bispebjerg, 2400, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Skin Neoplasms, Basal Cell Carcinoma, Anilides, Pyridines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: LEO Pharma, Copenhagen University.
Abstract (Originalsprache)
This study aimed to investigate the impact of ablative fractional laser (AFL) on hedgehog pathway gene expression in murine microscopic basal cell carcinomas (BCCs) and compare these results to the effect of topical treatment with vismodegib, an FDA-approved hedgehog inhibitor. In 25 mice, 1 cm 2 skin test sites ( n = 44) containing microscopic BCCs were exposed to one of three interventions: a single CO 2 AFL treatment (1 pulse, 40 mJ/microbeam, wavelength 10.6 μm, 5% density, pulse rate 250 Hz, n = 12), eight topical vismodegib treatments (3.8 mg/mL, n = 8), or combination of AFL and vismodegib treatments ( n = 9). Untreated controls were included for comparison ( n = 15). After 4 days, skin samples were analyzed for hedgehog gene expression ( Gli1 , Gli2 , and Ptch1 ) by qPCR and vismodegib concentrations by liquid chromatography mass spectrometry (data analyzed with two-tailed t -tests and linear regression). A single treatment with AFL monotherapy significantly reduced hedgehog gene expression compared to untreated controls ( Gli1 72.4% reduction, p = 0.003; Gli2 55.2%, p = 0.010; Ptch1 70.9%, p < 0.001). Vismodegib treatment also reduced hedgehog gene expression ( Gli1 91.6%; Gli2 83.3%; Ptch1 83.0%), significantly surpassing AFL monotherapy for two out of three genes ( Gli1 , p = 0.017; Gli2 , p = 0.007; Ptch1 , p = 0.15). AFL and vismodegib combination mirrored the effects of vismodegib monotherapy ( Gli1 , p = 0.424; Gli2 , p = 0.289; Ptch1 , p = 0.593), possibly due to comparable cutaneous vismodegib concentrations (mean ± SD, vismodegib monotherapy 850 ± 475 µmol/L; combination 1036 ± 824 µmol/L; p = 0.573). In conclusion, a single AFL treatment significantly reduced hedgehog gene expression in murine BCCs mimicking the effects of eight topical applications of vismodegib. Further studies are needed to assess whether AFL can be utilized for BCC treatment, either as monotherapy or in combination with other drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Copenhagen University Hospital Bispebjerg, 2400, Copenhagen, Denmark.
- Department of Pharmacy, University of Copenhagen, 2100, Copenhagen, Denmark.
- Department of Immunology and Microbiology, University of Copenhagen, 2200, Copenhagen, Denmark.
- Molecular Biomedicine, LEO Pharma A/S, 2750, Ballerup, Denmark.
- Department of Dermatology, Copenhagen University Hospital Bispebjerg, 2400, Copenhagen, Denmark. uffe.hoegh.olesen@regionh.dk.
Förderung
- LEO Pharma
- Copenhagen University
Zitieren
APA
Pedersen, K. K., Granborg, J. R., Lerche, C. M., Litman, T., Olesen, U. H., & Hædersdal, M. (2024). Ablative fractional laser treatment reduces hedgehog pathway gene expression in murine basal cell carcinomas. Lasers in Medical Science. https://doi.org/10.1007/s10103-024-03997-1
Vancouver
Pedersen KK, Granborg JR, Lerche CM, Litman T, Olesen UH, Hædersdal M. Ablative fractional laser treatment reduces hedgehog pathway gene expression in murine basal cell carcinomas. Lasers in Medical Science. 2024. doi:10.1007/s10103-024-03997-1
BibTeX
@article{Pedersen2024,
author = {Pedersen, Kristian Kåber and Granborg, Jonatan Riber and Lerche, Catharina Margrethe and Litman, Thomas and Olesen, Uffe Høgh and Hædersdal, Merete},
title = {Ablative fractional laser treatment reduces hedgehog pathway gene expression in murine basal cell carcinomas},
journal = {Lasers in Medical Science},
year = {2024},
doi = {10.1007/s10103-024-03997-1}
}
EUVIMED